Antibiotic-resistant Staphylococcus aureus and hospital antibiotic policies.
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001434:Bacteriophage Typing; D002701:Chloramphenicol / Q000494:pharmacology; D003023:Cloxacillin / Q000494:pharmacology; D003428:Cross Infection / Q000517:prevention & control; D004917:Erythromycin / Q000494:pharmacology; D006761:Hospitals; D006801:Humans; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D009675:Novobiocin / Q000494:pharmacology; D010284:Paratyphoid Fever / Q000150:complications; D010400:Penicillin G / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000517:prevention & control; D013210:Staphylococcus / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D010406:Penicillins; D009675:Novobiocin; D004917:Erythromycin; D002701:Chloramphenicol; D000667:Ampicillin; D003023:Cloxacillin; D010400:Penicillin G; D008712:Methicillin